Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

In utero beta 2 adrenergic agonist exposure and adverse neurophysiologic and behavioral outcomes.

Witter FR, Zimmerman AW, Reichmann JP, Connors SL.

Am J Obstet Gynecol. 2009 Dec;201(6):553-9. doi: 10.1016/j.ajog.2009.07.010. Review.

PMID:
19961985
2.

Does treatment of premature labor with terbutaline increase the risk of autism spectrum disorders?

Witter FR.

Am J Obstet Gynecol. 2011 Aug;205(2):e12; discussion e12-4. doi: 10.1016/j.ajog.2011.05.026. Epub 2011 May 14. No abstract available.

PMID:
21684516
3.

In utero beta 2 adrenergic agonist exposure and adverse neurophysiologic and behavioral outcomes.

Henry A, Kennedy D, Lowe S.

Am J Obstet Gynecol. 2010 Oct;203(4):e14; author reply e14-5. doi: 10.1016/j.ajog.2010.04.025. Epub 2010 Jun 11. No abstract available.

PMID:
20541172
4.

A critical appraisal of the potential harmful effects of terbutaline sulfate use in pregnancy.

Elliott JP, Morrison JC, Chauhan SP.

J Reprod Med. 2013 Mar-Apr;58(3-4):123-31. Review.

PMID:
23539880
5.

Tocolysis with beta-adrenergic receptor agonists.

Caughey AB, Parer JT.

Semin Perinatol. 2001 Aug;25(4):248-55. Review.

PMID:
11561912
6.

beta2-adrenergic receptor activation and genetic polymorphisms in autism: data from dizygotic twins.

Connors SL, Crowell DE, Eberhart CG, Copeland J, Newschaffer CJ, Spence SJ, Zimmerman AW.

J Child Neurol. 2005 Nov;20(11):876-84.

PMID:
16417856
7.

Reversing acute intrapartum fetal distress using tocolytic drugs.

Smith CV.

Clin Obstet Gynecol. 1991 Jun;34(2):352-9. Review. No abstract available.

PMID:
1678323
8.

Prescription drugs uses and effects. Bronchodilators: adrenoreceptor agonists.

Jordan S.

Nurs Stand. 2004 Apr 21-27;18(32):2p.. No abstract available.

PMID:
15132040
9.

Beta 2 adrenergic agents and autism.

Fox NS, Roman AS.

Am J Obstet Gynecol. 2010 Oct;203(4):e15; author reply e15-6. doi: 10.1016/j.ajog.2010.06.064. Epub 2010 Aug 16. No abstract available.

PMID:
20719293
10.

Beta-adrenergic agonists.

Boyle JG.

Clin Obstet Gynecol. 1995 Dec;38(4):688-96. Review. No abstract available.

PMID:
8616966
11.

Arg16 homozygosity of the beta2-adrenergic receptor improves the outcome after beta2-agonist tocolysis for preterm labor.

Landau R, Morales MA, Antonarakis SE, Blouin JL, Smiley RM.

Clin Pharmacol Ther. 2005 Dec;78(6):656-63.

PMID:
16338281
12.

Adrenergic bronchodilators: pharmacology and toxicology.

Reed CE.

J Allergy Clin Immunol. 1985 Aug;76(2 Pt 2):335-41.

PMID:
2862174
13.

Adverse and beneficial effects of tocolytic therapy.

Pryde PG, Besinger RE, Gianopoulos JG, Mittendorf R.

Semin Perinatol. 2001 Oct;25(5):316-40. Review.

PMID:
11707019
14.

Do tocolytic agents stop preterm labor? A critical and comprehensive review of efficacy and safety.

Higby K, Xenakis EM, Pauerstein CJ.

Am J Obstet Gynecol. 1993 Apr;168(4):1247-56; discussion 1256-9. Review.

PMID:
8097367
15.

beta-Agonist tocolytic therapy.

Lam F, Gill P.

Obstet Gynecol Clin North Am. 2005 Sep;32(3):457-84. Review.

PMID:
16125044
16.

Preterm labour management--an evidence--update.

Piyamongkol W.

J Med Assoc Thai. 2004 Oct;87 Suppl 3:S154-7.

PMID:
21213513
17.

Asthma and other allergic disorders in pregnancy.

Holbreich M.

Am Fam Physician. 1982 Mar;25(3):187-92.

PMID:
7064756
18.

Parotitis due to ritodrine tocolytic treatment for preterm labor.

Marioni G, Marchese-Ragona R, Ottaviano G, Campobasso C, Staffieri A.

Otolaryngol Head Neck Surg. 2005 Apr;132(4):665-6. No abstract available.

PMID:
15806068
20.

What's new in tocolytics.

Leonardi MR, Hankins GD.

Clin Perinatol. 1992 Jun;19(2):367-84. Review.

PMID:
1352193

Supplemental Content

Support Center